Table 3.
Clinical and radiological analysis between surgical (group A) and endovascular (group B) groups of patients
162 pts | Group A Surgical series, 118 pts | Group B Endovascular series, 44 | p-value |
---|---|---|---|
Mean age | 47.87 min = 18 max = 72 SD = 10.59 | 53.98 min = 10 max = 86 SD = 20.2 | |
Female | 60/118, 50.8% | 39/86, 88.6% | < 0.05 |
Location | Posterior circulation, 8 pts, 6.8% | Posterior circulation, 8 pts, 18.2% | |
ICA petrous, 3 pts, 2.5% | ICA petrous, 0% | ||
ICA cavernous, 25 pts, 21.2% | ICA cavernous, 16 pts, 36.4% | ||
ICA clinoid/sovraclinoid, 49, 38.1% | ICA clinoid/sovraclinoid, 19, 43.2% | ||
MCA, 22 pts, 18.6% | MCA, 1 pt, 2.3% | ||
AcoA, 15 pts, 12.7% | AcoA, 0% | ||
Neck | No proper neck, 30 pts, 25.4% | No proper neck, 4 pts, 9.1% | 0.02 |
Neck < = 4 mm, 65 pts, 55.1% | Neck < = 4 mm, 11 pts, 25% | 0,01 | |
Neck > 4 mm, 11 pts, 9.3% | Neck > 4 mm, 29 pts, 65.9% | < 0.01 | |
Neck calcified | 12, 10.2% | 0% | 0.19 |
Shape | Dissected = 0% | Dissected = 20, 45.5% | < 0.05 |
Saccular = 93, 78.8% | Saccular = 22, 50% | 0.07 | |
Saccular = 93, 78.8% | Saccular = 22, 50% | < 0.05 | |
Thrombosis | < 50% = 34, 28.8% | < 50% = 12, 27.3% | 0.51 |
> 50% = 2, 1.7% | > 50% = 2, 4.5% | 0.3 | |
No thrombosis = 84, 71.2% | No thrombosis = 32, 72.7% | 0.51 | |
Debut | Incidental = 10, 8.5% | Incidental = 1, 2.3% | 0.15 |
SAH symptoms = 28, 23.7% | SAH symptoms = 5, 11.4% | 0.06 | |
Seizure = 12, 10.2% | Seizure = 0% | 0.02 | |
TIA/ischemia = 17, 14.4% | TIA/ischemia = 0% | 0.03 | |
Headache = 0% | Headache = 13, 29.5% | < 0.01 | |
Mass effect/focal deficit = 50, 42.7% | Mass effect/focal deficit = 25, 56.8% | 0.07 | |
MRS pre-op | < 2 = 67, 56.8% | < 2 = 100% | < 0.01 |
> 2 = 51, 43.2% | |||
Hunt-Hess | HH 3–4 = 7, 5.9% | HH 3–4 = 9, 20.5% | < 0.01 |
HH 1–2 = 22, 18.6% | HH 1–2 = 1, 2.3% | 0.004 | |
HH 0 = 89, 75.4% | HH 0 = 34, 77.3% | 0.49 |